Home LiteratureArticle Details
PMID: 8855895 Published · ppublish English Comment Letter

Sheffield risk and treatment table for primary prevention of coronary heart disease.

Lancet (London, England) ·Vol. 348 ·No. 9033 ·1996-10-12 ·Pages 1039-40; author reply 1040-1

Wierzbicki AS, Reynolds TM

Abstract

暂无摘要

MeSH Terms
Age Factors Blood Pressure Cholesterol, HDL/blood Clinical Protocols Coronary Disease/economics,etiology,prevention & control Humans Hypertension/complications,prevention & control Hypertriglyceridemia/genetics,prevention & control Risk Factors Scotland Value of Life
Chemicals
Cholesterol, HDL
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Wierzbicki A S
Reynolds T M
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
DOI
10.1016/s0140-6736(05)64975-6
Published
1996-10-12
Pages
1039-40; author reply 1040-1
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Corrections
CommentOn
PMID: 8709740
External Links
PubMed source DOI: 10.1016/s0140-6736(05)64975-6 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2